MARAVAI LIFESCIENCES HOLDINGS, INC. 4

CEO Bernd Brust had 29,250 MRVI Class A shares withheld for taxes upon RSU vesting, leaving him with about 2.09 million shares in total.

On July 8, 2026, Maravai Lifesciences Holdings, Inc. CEO Bernd Brust had 29,250 shares of Class A Common Stock withheld by the company at an implied price of $5.92 per share, with an estimated value of about $173,160, to cover tax obligations arising from the vesting of his restricted stock unit awards. This Form 4 reflects a routine, tax-related disposition rather than an open-market sale, leaving him with direct ownership of 1,619,749 shares and an additional 466,771 shares held indirectly through The Bernd Brust Management Trust, for a total post-event holding of approximately 2,086,520 shares, which, using the same price reference, is worth roughly $12.35 million.

Filing Facts

CIK

1823239

Ticker

MRVI

Form

4

Source Type

fda

Accession

0001380632-26-000004

Alert Tier

5